Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) Debt to Equity (2024 - 2025)

Historic Debt to Equity for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $0.04.

  • Kura Oncology's Debt to Equity rose 7842.83% to $0.04 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.04, marking a year-over-year increase of 7842.83%. This contributed to the annual value of $0.02 for FY2024, which is N/A changed from last year.
  • Per Kura Oncology's latest filing, its Debt to Equity stood at $0.04 for Q3 2025, which was up 7842.83% from $0.03 recorded in Q2 2025.
  • Kura Oncology's 5-year Debt to Equity high stood at $0.04 for Q3 2025, and its period low was $0.02 during Q1 2024.